The latest price target for DexCom (NASDAQ:DXCM) was reported by Deutsche Bank on June 23, 2026. The analyst firm set a price target for $86.00 expecting DXCM to rise to within 12 months (a possible 24.71% upside). 56 analyst firms have reported ratings in the last year.

The latest analyst rating for DexCom (NASDAQ:DXCM) was provided by Deutsche Bank, and DexCom initiated their buy rating.

The last upgrade for DexCom Inc happened on December 2, 2025 when Morgan Stanley raised their price target to $75. Morgan Stanley previously had an equal-weight for DexCom Inc.

The last downgrade for DexCom Inc happened on January 12, 2026 when Barclays changed their price target from $80 to $71 for DexCom Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DexCom, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DexCom was filed on June 23, 2026 so you should expect the next rating to be made available sometime around June 23, 2027.

While ratings are subjective and will change, the latest DexCom (DXCM) rating was a initiated with a price target of $0.00 to $86.00. The current price DexCom (DXCM) is trading at is $68.96, which is within the analyst’s predicted range.